Dr. Harris Eyre
Harris trained in clinical medicine and neuroscience. He is now President and Chief Medical Officer of PRODEO, which propels novel brain health technology companies; supporting their business development, their product strategy and helping raise capital. He is also Co-Founder of the PRODEO Institute which – in partnership with the Organisation for Economic Co-operation and Development (OECD) and with funding from Gates Ventures, Johnson & Johnson, PwC and the Milken Institute – seeks to incubate new approaches to brain-based investing, economics and policy. Harris maintains advisory or adjunct roles with the American Psychological Association, the Global Brain Health Institute at the University of California San Francisco, the American Association of Geriatric Psychiatry, Baylor College of Medicine and Deakin University. He has authored over 100 book chapters and papers, for Lancet Neurology, World Psychiatry and The RSA Journal. He is also lead editor of “Convergence Mental Health: A Transdisciplinary Approach to Innovation”, recently published by Oxford University Press.